US firm Cardinal Health has
revealed plans to buy
pharmaceutical distributor Kinray
Inc for around US$1.3 billion.
The acquisition is aimed at
expanding Cardinal’s US retail
pharmacy distribution base by an
estimated 40%.
Kinray, a distributor of branded
and generic drugs, clocks around
US$3.5b in revenue per annum.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Nov 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Nov 10
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.